197 related articles for article (PubMed ID: 29241705)
1. Characterizing the impact of adaptive planning on image-guided perineal interstitial brachytherapy for gynecologic malignancies.
Gladwish A; Ravi A; Barbera L; Mendez L; Davidson M; D'Alimonte L; D'Souza D; Wronski M; Leung E
Brachytherapy; 2018; 17(2):352-359. PubMed ID: 29241705
[TBL] [Abstract][Full Text] [Related]
2. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
3. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
4. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
[TBL] [Abstract][Full Text] [Related]
6. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
[TBL] [Abstract][Full Text] [Related]
8. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
9. Inversely and adaptively planned interstitial brachytherapy: A single implant approach.
Hanania AN; Myers P; Yoder AK; Bulut A; Henry Yu Z; Eraj S; Bowers J; Bonnen MD; Echeverria A; Hall TR; Anderson ML; Ludwig M
Gynecol Oncol; 2019 Feb; 152(2):353-360. PubMed ID: 30449720
[TBL] [Abstract][Full Text] [Related]
10. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
11. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
Kim H; Beriwal S; Houser C; Huq MS
Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience.
Kashihara T; Murakami N; Tselis N; Kobayashi K; Tsuchida K; Shima S; Masui K; Yoshida K; Takahashi K; Inaba K; Umezawa R; Igaki H; Ito Y; Kato T; Uno T; Itami J
J Radiat Res; 2019 Jul; 60(4):501-508. PubMed ID: 31034570
[TBL] [Abstract][Full Text] [Related]
15. Outpatient template-guided permanent interstitial brachytherapy using
Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of interfractional variation of organs and displacement of catheters during high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Lee S; Rodney E; Traughber B; Biswas T; Colussi V; Podder T
Brachytherapy; 2017; 16(6):1192-1198. PubMed ID: 28993108
[TBL] [Abstract][Full Text] [Related]
17. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of removing rectal gas on high-dose-rate brachytherapy dose distributions for gynecologic cancers.
Vergalasova I; Ennis RD; Sayan M; Liu B; Yue NJ; Hathout L
J Appl Clin Med Phys; 2021 Feb; 22(2):35-41. PubMed ID: 33440079
[TBL] [Abstract][Full Text] [Related]
19. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
[TBL] [Abstract][Full Text] [Related]
20. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
